Pricing
BerGenBio
Contact
No bio yet
This person is not in the org chart
4 people, 0 jobs
This person is not in any offices
BerGenBio: Developing first-in-class AXL inhibitors for aggressive diseases, including advanced, treatment resistant cancers
Industries
Headquarters
Employees
Links
Aclaris Therapeutics
Nobias Therapeutics
Exai Bio
Ras Labs
Brookline Capital Markets
View more